相似文献
1
Toward a Next-Generation Liquid Biopsy for HPV+ HNSCC: Opportunities, Challenges, and the Road Ahead.
Clin Cancer Res. 2025 Aug 14;31(16):3359-3361. doi: 10.1158/1078-0432.CCR-25-1488.
2
Direct Comparison of Alternative Blood-Based Approaches for Early Detection and Diagnosis of HPV-Associated Head and Neck Cancers.
Clin Cancer Res. 2025 Aug 14;31(16):3483-3493. doi: 10.1158/1078-0432.CCR-24-2525.
3
Circulating Tumour DNA as a Complementary Tool for Treatment Evaluation in HPV-Associated Head and Neck Squamous Cell Carcinoma: An Observational Cohort Study.
Clin Otolaryngol. 2025 Apr 22. doi: 10.1111/coa.14317.
4
Current status of circulating tumor DNA and circulating cell alterations in HPV-associated head and neck cancer.
Oral Oncol. 2025 Aug;167:107417. doi: 10.1016/j.oraloncology.2025.107417. Epub 2025 Jun 13.
5
The molecular characteristics of recurrent/metastatic HPV-positive head and neck squamous cell carcinoma: A systematic review of the literature.
Clin Otolaryngol. 2024 Jul;49(4):384-403. doi: 10.1111/coa.14161. Epub 2024 Apr 24.
6
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
7
The Next Chapter in Cancer Diagnostics: Advances in HPV-Positive Head and Neck Cancer.
Biomolecules. 2024 Jul 30;14(8):925. doi: 10.3390/biom14080925.
8
Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance.
Clin Cancer Res. 2023 Oct 13;29(20):4306-4313. doi: 10.1158/1078-0432.CCR-23-1478.
9
Advances in human papillomavirus detection and molecular understanding in head and neck cancers: Implications for clinical management.
J Med Virol. 2024 Jun;96(6):e29746. doi: 10.1002/jmv.29746.
10
Evaluation of ctDNA-guided adjuvant therapy de-escalation in head and neck squamous cell carcinoma: a comparative cohort study.
Front Immunol. 2025 Aug 7;16:1576042. doi: 10.3389/fimmu.2025.1576042. eCollection 2025.
本文引用的文献
1
Direct Comparison of Alternative Blood-Based Approaches for Early Detection and Diagnosis of HPV-Associated Head and Neck Cancers.
Clin Cancer Res. 2025 Aug 14;31(16):3483-3493. doi: 10.1158/1078-0432.CCR-24-2525.
2
Clinical Validation of Human Papilloma Virus Circulating Tumor DNA for Early Detection of Residual Disease After Chemoradiation in Cervical Cancer.
J Clin Oncol. 2024 Feb 1;42(4):431-440. doi: 10.1200/JCO.23.00954. Epub 2023 Nov 16.
3
Circulating Tumor HPV DNA for Surveillance of HPV-Positive Oropharyngeal Squamous Cell Carcinoma: A Narrative Review.
JAMA Oncol. 2023 Dec 1;9(12):1716-1724. doi: 10.1001/jamaoncol.2023.4042.
4
Development of a high-performance multi-probe droplet digital PCR assay for high-sensitivity detection of human papillomavirus circulating tumor DNA from plasma.
Oral Oncol. 2023 Aug;143:106436. doi: 10.1016/j.oraloncology.2023.106436. Epub 2023 Jun 1.
5
Early HPV ctDNA Kinetics and Imaging Biomarkers Predict Therapeutic Response in p16+ Oropharyngeal Squamous Cell Carcinoma.
Clin Cancer Res. 2022 Jan 15;28(2):350-359. doi: 10.1158/1078-0432.CCR-21-2338. Epub 2021 Oct 26.
Zotero 插件